393 related articles for article (PubMed ID: 29943223)
1. Inhibition of endoplasmic reticulum stress by intermedin1-53 attenuates angiotensin II-induced abdominal aortic aneurysm in ApoE KO Mice.
Ni XQ; Lu WW; Zhang JS; Zhu Q; Ren JL; Yu YR; Liu XY; Wang XJ; Han M; Jing Q; Du J; Tang CS; Qi YF
Endocrine; 2018 Oct; 62(1):90-106. PubMed ID: 29943223
[TBL] [Abstract][Full Text] [Related]
2. Intermedin1-53 Attenuates Abdominal Aortic Aneurysm by Inhibiting Oxidative Stress.
Lu WW; Jia LX; Ni XQ; Zhao L; Chang JR; Zhang JS; Hou YL; Zhu Y; Guan YF; Yu YR; Du J; Tang CS; Qi YF
Arterioscler Thromb Vasc Biol; 2016 Nov; 36(11):2176-2190. PubMed ID: 27634835
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of endoplasmic reticulum stress signaling pathway: A new mechanism of statins to suppress the development of abdominal aortic aneurysm.
Li Y; Lu G; Sun D; Zuo H; Wang DW; Yan J
PLoS One; 2017; 12(4):e0174821. PubMed ID: 28369137
[TBL] [Abstract][Full Text] [Related]
4. Tauroursodeoxycholic Acid Attenuates Angiotensin II Induced Abdominal Aortic Aneurysm Formation in Apolipoprotein E-deficient Mice by Inhibiting Endoplasmic Reticulum Stress.
Qin Y; Wang Y; Liu O; Jia L; Fang W; Du J; Wei Y
Eur J Vasc Endovasc Surg; 2017 Mar; 53(3):337-345. PubMed ID: 27889204
[TBL] [Abstract][Full Text] [Related]
5. Intermedin
Ren JL; Hou YL; Ni XQ; Zhu Q; Chen Y; Zhang LS; Liu X; Xue CD; Wu N; Yu YR; Tang CS; Ning ZP; Chai SB; Qi YF
J Cardiovasc Pharmacol Ther; 2020 May; 25(3):251-264. PubMed ID: 31698947
[TBL] [Abstract][Full Text] [Related]
6. Intermedin1-53 protects against cardiac hypertrophy by inhibiting endoplasmic reticulum stress via activating AMP-activated protein kinase.
Lu WW; Zhao L; Zhang JS; Hou YL; Yu YR; Jia MZ; Tang CS; Qi YF
J Hypertens; 2015 Aug; 33(8):1676-87. PubMed ID: 26136070
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of Notch1-mediated inflammation by intermedin protects against abdominal aortic aneurysm via PI3K/Akt signaling pathway.
Ni XQ; Zhang YR; Jia LX; Lu WW; Zhu Q; Ren JL; Chen Y; Zhang LS; Liu X; Yu YR; Jia MZ; Ning ZP; Du J; Tang CS; Qi YF
Aging (Albany NY); 2021 Feb; 13(4):5164-5184. PubMed ID: 33535178
[TBL] [Abstract][Full Text] [Related]
8. Targeting vascular smooth muscle cell dysfunction with xanthine derivative KMUP-3 inhibits abdominal aortic aneurysm in mice.
Lai CH; Chang CW; Lee FT; Kuo CH; Hsu JH; Liu CP; Wu HL; Yeh JL
Atherosclerosis; 2020 Mar; 297():16-24. PubMed ID: 32059119
[TBL] [Abstract][Full Text] [Related]
9. Endogenous intermedin protects against intimal hyperplasia by inhibiting endoplasmic reticulum stress.
Xue CD; Chen Y; Ren JL; Zhang LS; Liu X; Yu YR; Tang CS; Qi YF
Peptides; 2019 Nov; 121():170131. PubMed ID: 31408662
[TBL] [Abstract][Full Text] [Related]
10. Pravastatin activates activator protein 2 alpha to augment the angiotensin II-induced abdominal aortic aneurysms.
Ma H; Liang WJ; Shan MR; Wang XQ; Zhou SN; Chen Y; Guo T; Li P; Yu HY; Liu C; Yin YL; Wang YL; Dong B; Pang XY; Wang SX
Oncotarget; 2017 Feb; 8(9):14294-14305. PubMed ID: 28179583
[TBL] [Abstract][Full Text] [Related]
11. Intermedin
Ren JL; Chen Y; Zhang LS; Zhang YR; Liu SM; Yu YR; Jia MZ; Tang CS; Qi YF; Lu WW
Cell Death Dis; 2021 May; 12(5):436. PubMed ID: 33934111
[TBL] [Abstract][Full Text] [Related]
12. Intermedin
Zhang JS; Hou YL; Lu WW; Ni XQ; Lin F; Yu YR; Tang CS; Qi YF
J Atheroscler Thromb; 2016 Nov; 23(11):1294-1306. PubMed ID: 27052784
[TBL] [Abstract][Full Text] [Related]
13. Rapamycin Treatment Attenuates Angiotensin II -induced Abdominal Aortic Aneurysm Formation via VSMC Phenotypic Modulation and Down-regulation of ERK1/2 Activity.
Li FF; Shang XK; Du XL; Chen S
Curr Med Sci; 2018 Feb; 38(1):93-100. PubMed ID: 30074157
[TBL] [Abstract][Full Text] [Related]
14. Licochalcone A attenuates abdominal aortic aneurysm induced by angiotensin II via regulating the miR-181b/SIRT1/HO-1 signaling.
Hou X; Yang S; Zheng Y
J Cell Physiol; 2019 May; 234(5):7560-7568. PubMed ID: 30417353
[TBL] [Abstract][Full Text] [Related]
15. Calorie restriction protects against experimental abdominal aortic aneurysms in mice.
Liu Y; Wang TT; Zhang R; Fu WY; Wang X; Wang F; Gao P; Ding YN; Xie Y; Hao DL; Chen HZ; Liu DP
J Exp Med; 2016 Oct; 213(11):2473-2488. PubMed ID: 27670594
[TBL] [Abstract][Full Text] [Related]
16. Targeting mitochondrial fission as a potential therapeutic for abdominal aortic aneurysm.
Cooper HA; Cicalese S; Preston KJ; Kawai T; Okuno K; Choi ET; Kasahara S; Uchida HA; Otaka N; Scalia R; Rizzo V; Eguchi S
Cardiovasc Res; 2021 Feb; 117(3):971-982. PubMed ID: 32384150
[TBL] [Abstract][Full Text] [Related]
17. Cysteine-rich protein 2 deficiency attenuates angiotensin II-induced abdominal aortic aneurysm formation in mice.
Chen CH; Ho HH; Jiang WC; Ao-Ieong WS; Wang J; Orekhov AN; Sobenin IA; Layne MD; Yet SF
J Biomed Sci; 2022 Apr; 29(1):25. PubMed ID: 35414069
[TBL] [Abstract][Full Text] [Related]
18. Aldehyde dehydrogenase 2 protects against abdominal aortic aneurysm formation by reducing reactive oxygen species, vascular inflammation, and apoptosis of vascular smooth muscle cells.
Tsai SH; Hsu LA; Tsai HY; Yeh YH; Lu CY; Chen PC; Wang JC; Chiu YL; Lin CY; Hsu YJ
FASEB J; 2020 Jul; 34(7):9498-9511. PubMed ID: 32463165
[TBL] [Abstract][Full Text] [Related]
19. β-Arrestin-2 deficiency attenuates abdominal aortic aneurysm formation in mice.
Trivedi DB; Loftin CD; Clark J; Myers P; DeGraff LM; Cheng J; Zeldin DC; Langenbach R
Circ Res; 2013 Apr; 112(9):1219-29. PubMed ID: 23524589
[TBL] [Abstract][Full Text] [Related]
20. Epidermal growth factor receptor inhibitor protects against abdominal aortic aneurysm in a mouse model.
Obama T; Tsuji T; Kobayashi T; Fukuda Y; Takayanagi T; Taro Y; Kawai T; Forrester SJ; Elliott KJ; Choi E; Daugherty A; Rizzo V; Eguchi S
Clin Sci (Lond); 2015 May; 128(9):559-65. PubMed ID: 25531554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
